AU4261196A - Use of 2-(4-(azolylbutyl)piperazinyl-(methyl)benzimidazole derivatives for preparing drugs for treating or preventing asthma - Google Patents

Use of 2-(4-(azolylbutyl)piperazinyl-(methyl)benzimidazole derivatives for preparing drugs for treating or preventing asthma

Info

Publication number
AU4261196A
AU4261196A AU42611/96A AU4261196A AU4261196A AU 4261196 A AU4261196 A AU 4261196A AU 42611/96 A AU42611/96 A AU 42611/96A AU 4261196 A AU4261196 A AU 4261196A AU 4261196 A AU4261196 A AU 4261196A
Authority
AU
Australia
Prior art keywords
azolylbutyl
piperazinyl
methyl
treating
benzimidazole derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU42611/96A
Other versions
AU714581B2 (en
Inventor
Maria Rosa Cuberes-Altisent
Jordi Frigola-Constansa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Esteve Pharmaceuticals SA
Original Assignee
Laboratorios del Dr Esteve SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios del Dr Esteve SA filed Critical Laboratorios del Dr Esteve SA
Publication of AU4261196A publication Critical patent/AU4261196A/en
Application granted granted Critical
Publication of AU714581B2 publication Critical patent/AU714581B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
AU42611/96A 1994-12-08 1995-12-06 Use of 2-(4-(azolylbutyl)piperazinyl-(methyl)benzimidazole derivatives for preparing drugs for treating or preventing asthma Ceased AU714581B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9414766A FR2727865B1 (en) 1994-12-08 1994-12-08 USE OF 2- (4- (AZOLYBUTYL) -PIPERAZINYL- (METHYL)) - BENZIMIDAZOLE DERIVATIVES AND THEIR SALTS FOR THE PREPARATION OF MEDICINAL PRODUCTS FOR THE TREATMENT OR PROPHYLAXIS OF ASTHMA
FR94/14766 1994-12-08
PCT/EP1995/004884 WO1996017609A1 (en) 1994-12-08 1995-12-06 Use of 2-[4-(azolylbutyl)piperazinyl-(methyl)]benzimidazole derivatives for preparing drugs for treating or preventing asthma

Publications (2)

Publication Number Publication Date
AU4261196A true AU4261196A (en) 1996-06-26
AU714581B2 AU714581B2 (en) 2000-01-06

Family

ID=9469596

Family Applications (1)

Application Number Title Priority Date Filing Date
AU42611/96A Ceased AU714581B2 (en) 1994-12-08 1995-12-06 Use of 2-(4-(azolylbutyl)piperazinyl-(methyl)benzimidazole derivatives for preparing drugs for treating or preventing asthma

Country Status (9)

Country Link
EP (1) EP0741571A1 (en)
JP (1) JPH09508923A (en)
AU (1) AU714581B2 (en)
BR (1) BR1100852A (en)
CA (1) CA2182904A1 (en)
ES (1) ES2105986B1 (en)
FR (1) FR2727865B1 (en)
WO (1) WO1996017609A1 (en)
ZA (1) ZA9510435B (en)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4200641A (en) * 1976-12-21 1980-04-29 Janssen Pharmaceutica, N.V. 1-[(Heterocyclyl)-alkyl]-4-diarylmethoxy piperidine derivatives
JPH0383924A (en) * 1989-08-28 1991-04-09 Kanebo Ltd Composition for percutaneous administration
FR2665161B1 (en) * 1990-07-26 1992-11-27 Esteve Labor Dr NOVEL BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR APPLICATION AS MEDICAMENTS.
FR2668150B1 (en) * 1990-10-17 1994-11-18 Theramex NOVEL DERIVATIVES OF TERBUTYLPHENYL 1-AMINO 4-HYDROXYBUTANE, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2674856B1 (en) * 1991-04-05 1993-07-30 Esteve Labor Dr NOVEL NON - SEDATIVE ANTIHISTAMINS, DERIVATIVES OF BENZIMIDAZOLE, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS.

Also Published As

Publication number Publication date
EP0741571A1 (en) 1996-11-13
ES2105986A1 (en) 1997-10-16
WO1996017609A1 (en) 1996-06-13
FR2727865A1 (en) 1996-06-14
FR2727865B1 (en) 1997-07-18
BR1100852A (en) 1999-10-13
CA2182904A1 (en) 1996-06-13
JPH09508923A (en) 1997-09-09
ZA9510435B (en) 1996-06-14
ES2105986B1 (en) 1998-07-01
AU714581B2 (en) 2000-01-06

Similar Documents

Publication Publication Date Title
AU4600493A (en) Monohydrate of 5-(2-(4-(1,2 benzisothiazol-3-yl) -1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride
AU4715796A (en) Use of carotinoids for preparing medicaments for treating dermatoses
NO984084D0 (en) 4-Amino-pyrimidine derivatives, medicaments containing these compounds, their use and method of preparation thereof
ZA975675B (en) Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one
PL342840A1 (en) Pharmaceutical formulation comprising a 2- [[(2- pyridinyl) methyl] sulfinyl] benzimidazole having anti-ulcer activity and a process for the preparation of such formulation
AU782631C (en) Novel heterocyclic compounds and salts thereof and medicinal use of the same
AP2000001829A0 (en) Substituted thiazolidinedione derivative process for its preparation and its pharmaceutical use
NO307930B1 (en) Benzo [f] quinolinones, pharmaceutical formulation comprising the same and use of the same for the preparation of formulation for treatment
NO20002174D0 (en) Process for the preparation of thiazolidinedione derivatives
AU2002300593A1 (en) Process for the preparation of thiazolidinedione derivatives
AU1858992A (en) 2-(1-piperidyl)ethanol derivatives, their preparation and their therapeutic application
AU1530195A (en) Halogenated derivatives of 2,3'-(o)-cyclocytidine compounds and process for production thereof
HUP0001459A3 (en) Process for the preparation of substituted thiazolidinedione derivatives
AU4261196A (en) Use of 2-(4-(azolylbutyl)piperazinyl-(methyl)benzimidazole derivatives for preparing drugs for treating or preventing asthma
FR2660862B1 (en) THERAPEUTIC APPLICATION OF HISTAMINE DERIVATIVES, NEW HISTAMINE DERIVATIVE AND USE OF THESE DERIVATIVES FOR THE PREPARATION OF MEDICAMENTS.
AU5553200A (en) Process for the preparation of paroxetine and structurally related compounds
IL125605A0 (en) Novel substituted n-methyl-n-(4(4-(1h-benzimidazol-2-yl)[1,4]diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
NO972450D0 (en) Substituted 2- (phosphinyloxymethyl) -1,2,5-thiadiazolidin-3-one 1,1-dioxides and preparations and method of use thereof
PL307286A1 (en) Novel derivatives of 1-[2-(1h-inden-3-yl) ethyl]-4-(naphten-1-yl) piperasine, method of obtaining them, drug and pharmaceutical agent
ZA962060B (en) Topical ophthalmic composition comprising a 2-(4-(azolylbutyl)-piperazinyl)benzimidazole derivative in particular for the treatment of allergic conjunctivitis
AU7358896A (en) 1-{4-(4'-sulfanilyl)phenyl}urea and derivatives for the treatment of leishmaniasis
NZ301453A (en) 4-(substituted phenyl),4-(substituted carboxyl, carboxylamide or alkyl)-cyclohexan-1-one derivatives and medicaments
EE200000369A (en) Process for the preparation of isopropylmethyl [2- (3-n-propoxyphenoxy) ethyl] amine
AU8626398A (en) Inhibitors of the phosphodiesterase-4 for the treatment of allergic rhinitis
NO972435D0 (en) 2- (2,3,5,6-Tetrafluoro-4-pyridyl) -1,2,5-tradiazolidin-3-one 1,1-dioxides and preparations and methods of use thereof

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired